Page last updated: 2024-08-25

isoscopoletin and hymecromone

isoscopoletin has been researched along with hymecromone in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Adachi, I; Hirono, S; Kato, A; Kobayashi, K; Minoshima, Y; Narukawa, K; Nash, RJ1
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P1
Ge, GB; Gonzalez, FJ; Li, SY; Liu, Y; Wang, JJ; Wang, P; Xia, YL1

Other Studies

3 other study(ies) available for isoscopoletin and hymecromone

ArticleYear
6,7-Dihydroxy-4-phenylcoumarin as inhibitor of aldose reductase 2.
    Bioorganic & medicinal chemistry letters, 2010, Oct-01, Volume: 20, Issue:19

    Topics: Aldehyde Reductase; Animals; Binding Sites; Computer Simulation; Coumarins; Galactitol; L-Iditol 2-Dehydrogenase; Lens, Crystalline; Protein Structure, Tertiary; Rats; Rhodanine; Structure-Activity Relationship; Thiazolidines

2010
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
    Bioorganic & medicinal chemistry, 2012, Nov-15, Volume: 20, Issue:22

    Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship

2012
Synthesis and structure-activity relationship of coumarins as potent Mcl-1 inhibitors for cancer treatment.
    Bioorganic & medicinal chemistry, 2021, 01-01, Volume: 29

    Topics: A549 Cells; Antineoplastic Agents; Cell Proliferation; Cell Survival; Coumarins; Dose-Response Relationship, Drug; Humans; Models, Molecular; Molecular Structure; Myeloid Cell Leukemia Sequence 1 Protein; Structure-Activity Relationship; Tumor Cells, Cultured

2021